Epigenetic inactivation of RASSF2 in oral squamous cell carcinoma

Takashi Imai1, Minoru Toyota, Hiromu Suzuki

  • 1Department of Molecular Biology, Cancer Research Institute, Sapporo Medical University, Sapporo 060-8543, Japan.

Cancer Science
|February 26, 2008
PubMed

Insights

Epigenetic silencing of RASSF2 via DNA methylation is common in oral squamous cell carcinoma (OSCC). Restoring RASSF2 function suppresses tumor growth and may offer a new therapeutic target for OSCC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Genetic and epigenetic alterations in tumor-suppressor genes are crucial in human neoplasia.
  • Ras signaling activation is frequent in oral squamous cell carcinoma (OSCC), but underlying mechanisms are unclear, especially in Japanese populations.
  • Ras association family (RASSF) genes are implicated in tumor suppression.

Purpose of the Study:

  • To investigate the role of RASSF gene family, particularly RASSF2, in oral squamous cell carcinoma (OSCC) development.
  • To determine the mechanisms of RASSF2 dysregulation, focusing on epigenetic modifications like DNA methylation.
  • To evaluate the functional impact of RASSF2 on OSCC cell behavior and its potential as a therapeutic target.

Main Methods:

  • Analysis of RASSF gene expression in OSCC cell lines.
  • Detection of RASSF2 and other RASSF gene methylation in primary OSCC samples.
  • Functional studies involving ectopic expression of wild-type and mutant RASSF2 in OSCC cells.
  • Genomic screening to identify genes regulated by RASSF2.

Main Results:

  • RASSF2 was frequently downregulated by DNA methylation in OSCC cell lines.
  • Aberrant methylation of RASSF2 was found in 26% of primary OSCC, and at least one RASSF gene was methylated in 39%.
  • Ectopic RASSF2 expression suppressed OSCC cell growth and induced apoptosis, dependent on its Ras-association domain.
  • RASSF2 suppressed genes involved in immune response, angiogenesis, and metastasis.

Conclusions:

  • Epigenetic inactivation of RASSF2 through DNA methylation is a significant event in OSCC tumorigenesis.
  • RASSF2 acts as a tumor suppressor in OSCC, regulating critical cellular processes.
  • RASSF2 represents a potential molecular target for OSCC diagnosis and therapy.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.